Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells

Japanese Journal of Cancer Research

Volumn 92, Issue 3, 2001, Pages 321-327

  Asada Mikami, Rumiko ^a,c   Heike, Yuji ^d   Kanai, Sachiyo ^a   Azuma, Masato ^a   Shirakawa, Kazuo ^a   Takaue, Yoichi ^b   Krasnykh, Victor ^e   Curiel, David T ^e   Terada, Masaaki ^a   Abe, Tatsuo ^c   Wakasugi, Hiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adenoviridae; Coxsackie adenovirus receptor; Dendritic cell; Gene tranfer; Integrins

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; B7 ANTIGEN; CD1 ANTIGEN; CD11 ANTIGEN; CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTEGRIN; INTERLEUKIN 4; LUCIFERASE; LYMPHOCYTE SURFACE MARKER; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ADENOVIRUS; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INCUBATION TIME; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CULTURE; VIRUS RECOMBINANT;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, CD14; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GENES, REPORTER; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPHENOTYPING; INTEGRINS; INTERLEUKIN-4; LUCIFERASES; LUNG NEOPLASMS; OLIGOPEPTIDES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035070929     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01098.x     Document Type: Article

References (33)

1. Dendritic cells: Unique leukocyte populations which control the primary immune response
2. Dendritic cell immuno-therapy in disseminated parathyroid carcinoma
3. Generation of bcr-abl specific cytotoxic T-lymphocytes by using dendritic cells pulsed with bcr-abl (β3α2) peptide: Its applicability for donor leukocyte transfusions in marrow grafted CML patients
4. + cells
5. Dendritic cell vaccines for cancer immunotherapy
6. Targeted adenoviral vectors for cancer gene therapy
7. A comparison of gene transfer methods in human dendritic cells
8. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
9. The murine CAR homolog is a receptor for coxsackie viruses and adenoviruses
10. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
11. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-indenpendent cell entry mechanism
12. + peripheral blood monocytes
13. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob
14. A simple and efficient method for purification of infectious recombinant adenovirus
15. + dendritic cells
16. Increased in vivo gene transfer by adenovirus vectors containing chimeric fiber protein
17. High gradient magnetic cell separation with MACS
18. Complementation of a fiber mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fiber protein
19. Dendritic cells and the control of immunity
20. Origin, maturation and antigen presenting function of dendritic cells
21. Dendritic cells hold promise for immunotherapy
22. Dendritic cells
23. Dendritic cells as adjuvants for immune-mediated resistance to tumors
24. Development of dendritic cell-based genetic vaccines for cancer
25. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
26. Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation
27. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: Molecular and clinical pharmacology
28. Active specific T-cell-based immunotherapy for cancer: Nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects
29. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1
30. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells
31. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
32. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
33. Induction of Th1 response by dendritic cells pulsed with autologous melanoma apoptotic bodies